These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16223974)

  • 1. Antagonist-induced, activation function-2-independent estrogen receptor alpha phosphorylation.
    Lipfert L; Fisher JE; Wei N; Scafonas A; Su Q; Yudkovitz J; Chen F; Warrier S; Birzin ET; Kim S; Chen HY; Tan Q; Schmidt A; Dininno F; Rohrer SP; Hammond ML; Rodan GA; Freedman LP; Reszka AA
    Mol Endocrinol; 2006 Mar; 20(3):516-33. PubMed ID: 16223974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus.
    Scafonas A; Reszka AA; Kimmel DB; Hou XS; Su Q; Birzin ET; Kim S; Chen HY; Tan Q; Roher SP; Dininno F; Hammond ML; Rodan GA; Towler DA; Schmidt A
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):197-206. PubMed ID: 18508261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera.
    Chen D; Washbrook E; Sarwar N; Bates GJ; Pace PE; Thirunuvakkarasu V; Taylor J; Epstein RJ; Fuller-Pace FV; Egly JM; Coombes RC; Ali S
    Oncogene; 2002 Jul; 21(32):4921-31. PubMed ID: 12118371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fulvestrant (ICI 182,780)-dependent interacting proteins mediate immobilization and degradation of estrogen receptor-alpha.
    Long X; Nephew KP
    J Biol Chem; 2006 Apr; 281(14):9607-15. PubMed ID: 16459337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptor α L543A,L544A mutation changes antagonists to agonists, correlating with the ligand binding domain dimerization associated with DNA binding activity.
    Arao Y; Hamilton KJ; Coons LA; Korach KS
    J Biol Chem; 2013 Jul; 288(29):21105-21116. PubMed ID: 23733188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305.
    Held JM; Britton DJ; Scott GK; Lee EL; Schilling B; Baldwin MA; Gibson BW; Benz CC
    Mol Cancer Res; 2012 Aug; 10(8):1120-32. PubMed ID: 22669764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of Estrogen Receptor α at serine 118 directs recruitment of promoter complexes and gene-specific transcription.
    Duplessis TT; Williams CC; Hill SM; Rowan BG
    Endocrinology; 2011 Jun; 152(6):2517-26. PubMed ID: 21505052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between MAP kinase and oestrogen receptor in human breast cancer.
    McGlynn LM; Tovey S; Bartlett JM; Doughty J; Cooke TG; Edwards J
    Eur J Cancer; 2013 Apr; 49(6):1176-86. PubMed ID: 23265704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
    J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen and ICI 182,780 negatively influenced cardiac cell growth via an estrogen receptor-independent mechanism.
    Mercier I; Mader S; Calderone A
    Cardiovasc Res; 2003 Oct; 59(4):883-92. PubMed ID: 14553828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diarylheptanoid phytoestrogens isolated from the medicinal plant Curcuma comosa: biologic actions in vitro and in vivo indicate estrogen receptor-dependent mechanisms.
    Winuthayanon W; Piyachaturawat P; Suksamrarn A; Ponglikitmongkol M; Arao Y; Hewitt SC; Korach KS
    Environ Health Perspect; 2009 Jul; 117(7):1155-61. PubMed ID: 19654927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization.
    Chen D; Pace PE; Coombes RC; Ali S
    Mol Cell Biol; 1999 Feb; 19(2):1002-15. PubMed ID: 9891036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective estrogen receptor down-regulator and selective estrogen receptor modulators differentially regulate lactotroph proliferation.
    Kansra S; Chen S; Bangaru ML; Sneade L; Dunckley JA; Ben-Jonathan N
    PLoS One; 2010 Apr; 5(4):e10060. PubMed ID: 20419096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of genistein as a selective estrogen receptor beta agonist on the expression of Calbindin-D9k in the uterus of immature rats.
    Lee GS; Choi KC; Kim HJ; Jeung EB
    Toxicol Sci; 2004 Dec; 82(2):451-7. PubMed ID: 15456916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradation.
    Tsai HW; Katzenellenbogen JA; Katzenellenbogen BS; Shupnik MA
    Endocrinology; 2004 Jun; 145(6):2730-8. PubMed ID: 15033909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH; Rowan BG
    Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen modulates in vitro T cell responses in a concentration- and receptor-dependent manner: effects on intracellular molecular targets and antioxidant enzymes.
    Priyanka HP; Krishnan HC; Singh RV; Hima L; Thyagarajan S
    Mol Immunol; 2013 Dec; 56(4):328-39. PubMed ID: 23911387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein.
    Saville B; Poukka H; Wormke M; Janne OA; Palvimo JJ; Stoner M; Samudio I; Safe S
    J Biol Chem; 2002 Jan; 277(4):2485-97. PubMed ID: 11696545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.